2022年6月28日,科睿唯安(Clarivate Analytics,原汤森路透知识产权与科技事业部)发布了一年一度的期刊引证报告(Journal Citation Reports)。AME旗下杂志Translational Lung Cancer Research(中文名为《肺癌转化研究》杂志,简称TLCR杂志,图1)获得最...
Globally, cancer incidence and death are rising, with lung cancer being the most commonly diagnosed form of cancer (11.6% of the total cases). In the United States, in 2022, there are expected to be ~ 236,740 new lung cancer cases, with ~ 130,180 human demise [1]. Lung can...
Lung cancer is the leading cause of cancer-associated mortality worldwide1. Here we analysed 1,644 tumour regions sampled at surgery or during follow-up from the first 421 patients with non-small cell lung cancer prospectively enrolled into the TRACERx study. This project aims to decipher lung ...
Lung cancer accounts for about 13% of all cancers and is the number one cause of cancer-related death worldwide which leads to more deaths than colorectal, breast, brain, and prostate cancers [1,2]. In 2022, the American Cancer Society estimated 236,740 new cases and 130,180 deaths from...
This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on screening for lung cancer summarizes published
People with lung cancer and others affected by the condition are using social media to share information and support, but little is known about how these behaviours vary between different platforms. To investigate this, we extracted posts from Twitter (using relevant hashtags), the Lung Cancer Supp...
No cancer can develop without the presence of molecular abnormalities, and lung cancer is no exception. Thus far, several signaling axes have been accused of being involved in the pathogenesis of this cancer; however, it seems this is the overlap of the oncogenic pathways that contributes to ...
Lung CancerLung Cancer LymphomaLymphomaLymphomaLymphomaLymphoma Myeloma Rare CancersRare CancersRare CancersRare Cancers Sarcoma Skin CancerSkin Cancer Thyroid Cancer Spotlight News Videos Conferences Events Resources SubscribeAdvertisement Educated Patient® Lung Cancer Summit: June 25, 2022 : Episode 3...
Lung cancer in India is a very serious problem. Healthcare facilities, both private and public, have made significant efforts in mitigating the impact. It is the fourth most common cancer in India, accounting for 5.9% of all cancer cases. This scenario creates a conducive environment for player...
Non-small cell lung cancer (NSCLC) is one of the most threatening malignancies to human health and life. In most cases, patients with NSCLC are already at an advanced stage when they are diagnosed. In recent years, lung cancer has made great progress in